1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 Kasai, T. Miyamoto, K. Tochio, N. Tomizawa, T. Koshiba, S. Watanabe, S. Harada, T. Kigawa, T. Yokoyama, S. RIKEN Structural Genomics/Proteomics Initiative (RSGI) http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic C3 H7 N O2 89.093 y ALANINE L-peptide linking C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H8 N2 O3 132.118 y ASPARAGINE L-peptide linking C4 H7 N O4 133.103 y ASPARTIC ACID L-peptide linking C3 H7 N O2 S 121.158 y CYSTEINE L-peptide linking C5 H10 N2 O3 146.144 y GLUTAMINE L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H10 N3 O2 1 156.162 y HISTIDINE L-peptide linking C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking C5 H11 N O2 S 149.211 y METHIONINE L-peptide linking C9 H11 N O2 165.189 y PHENYLALANINE L-peptide linking C5 H9 N O2 115.130 y PROLINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C4 H9 N O3 119.119 y THREONINE L-peptide linking C9 H11 N O3 181.189 y TYROSINE L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking To be Published 0353 Solution structure of the human STAP2 SH2 domain 10.2210/pdb2el8/pdb pdb_00002el8 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 13022.834 Signal-transducing adaptor protein 2 SH2 domain 1 man polymer STAP-2, Breast tumor kinase substrate, BRK substrate no no GSSGSSGEVLAKEEARRALETPSCFLKVSRLEAQLLLERYPECGNLLLRPSGDGADGVSVTTRQMHNGTHVVRHYKVKRE GPKYVIDVEQPFSCTSLDAVVNYFVSHTKKALVPFLLD GSSGSSGEVLAKEEARRALETPSCFLKVSRLEAQLLLERYPECGNLLLRPSGDGADGVSVTTRQMHNGTHVVRHYKVKRE GPKYVIDVEQPFSCTSLDAVVNYFVSHTKKALVPFLLD A hss001002297.1 polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n human Homo sample Cell-free protein synthesis STAP2 9606 Homo sapiens PLASMID P061218-22 RIKEN Structural Genomics/Proteomics Initiative RSGI NPPSFA, National Project on Protein Structural and Functional Analyses database_2 pdbx_nmr_software pdbx_nmr_spectrometer pdbx_struct_assembly pdbx_struct_oper_list struct_ref_seq_dif repository Initial release Version format compliance Data collection Database references Derived calculations 1 0 2007-10-02 1 1 2011-07-13 1 2 2022-03-09 _database_2.pdbx_DOI _database_2.pdbx_database_accession _pdbx_nmr_software.name _pdbx_nmr_spectrometer.model _struct_ref_seq_dif.details Y PDBJ Y PDBJ 2007-03-26 REL REL structures with the least restraint violations, structures with the lowest energy, target function 100 20 3D_15N-separated_NOESY 3D_13C-separated_NOESY 120mM 7.0 ambient 298 K torsion angle dynamics, restrainted molecular dynamics 1 lowest energy 1.00mM SH2 domain U-15N, 13C; 20mM d-Tris-HCl(pH 7.0); 100mM NaCl; 1mM d-DTT; 0.02% NaN3; 90% H2O, 10% D2O 90% H2O/10% D2O Bruker collection XwinNMR 3.5 Delaglio, F. processing NMRPipe 20031121 Johnson, B.A. data analysis NMRView 5.0.4 Kobayashi, N. data analysis KUJIRA 0.9810 Guntert, P. structure solution CYANA 2.0.17 Guntert, P. refinement CYANA 2.0.17 800 Bruker AVANCE GLY 1 n 1 GLY 1 A SER 2 n 2 SER 2 A SER 3 n 3 SER 3 A GLY 4 n 4 GLY 4 A SER 5 n 5 SER 5 A SER 6 n 6 SER 6 A GLY 7 n 7 GLY 7 A GLU 8 n 8 GLU 8 A VAL 9 n 9 VAL 9 A LEU 10 n 10 LEU 10 A ALA 11 n 11 ALA 11 A LYS 12 n 12 LYS 12 A GLU 13 n 13 GLU 13 A GLU 14 n 14 GLU 14 A ALA 15 n 15 ALA 15 A ARG 16 n 16 ARG 16 A ARG 17 n 17 ARG 17 A ALA 18 n 18 ALA 18 A LEU 19 n 19 LEU 19 A GLU 20 n 20 GLU 20 A THR 21 n 21 THR 21 A PRO 22 n 22 PRO 22 A SER 23 n 23 SER 23 A CYS 24 n 24 CYS 24 A PHE 25 n 25 PHE 25 A LEU 26 n 26 LEU 26 A LYS 27 n 27 LYS 27 A VAL 28 n 28 VAL 28 A SER 29 n 29 SER 29 A ARG 30 n 30 ARG 30 A LEU 31 n 31 LEU 31 A GLU 32 n 32 GLU 32 A ALA 33 n 33 ALA 33 A GLN 34 n 34 GLN 34 A LEU 35 n 35 LEU 35 A LEU 36 n 36 LEU 36 A LEU 37 n 37 LEU 37 A GLU 38 n 38 GLU 38 A ARG 39 n 39 ARG 39 A TYR 40 n 40 TYR 40 A PRO 41 n 41 PRO 41 A GLU 42 n 42 GLU 42 A CYS 43 n 43 CYS 43 A GLY 44 n 44 GLY 44 A ASN 45 n 45 ASN 45 A LEU 46 n 46 LEU 46 A LEU 47 n 47 LEU 47 A LEU 48 n 48 LEU 48 A ARG 49 n 49 ARG 49 A PRO 50 n 50 PRO 50 A SER 51 n 51 SER 51 A GLY 52 n 52 GLY 52 A ASP 53 n 53 ASP 53 A GLY 54 n 54 GLY 54 A ALA 55 n 55 ALA 55 A ASP 56 n 56 ASP 56 A GLY 57 n 57 GLY 57 A VAL 58 n 58 VAL 58 A SER 59 n 59 SER 59 A VAL 60 n 60 VAL 60 A THR 61 n 61 THR 61 A THR 62 n 62 THR 62 A ARG 63 n 63 ARG 63 A GLN 64 n 64 GLN 64 A MET 65 n 65 MET 65 A HIS 66 n 66 HIS 66 A ASN 67 n 67 ASN 67 A GLY 68 n 68 GLY 68 A THR 69 n 69 THR 69 A HIS 70 n 70 HIS 70 A VAL 71 n 71 VAL 71 A VAL 72 n 72 VAL 72 A ARG 73 n 73 ARG 73 A HIS 74 n 74 HIS 74 A TYR 75 n 75 TYR 75 A LYS 76 n 76 LYS 76 A VAL 77 n 77 VAL 77 A LYS 78 n 78 LYS 78 A ARG 79 n 79 ARG 79 A GLU 80 n 80 GLU 80 A GLY 81 n 81 GLY 81 A PRO 82 n 82 PRO 82 A LYS 83 n 83 LYS 83 A TYR 84 n 84 TYR 84 A VAL 85 n 85 VAL 85 A ILE 86 n 86 ILE 86 A ASP 87 n 87 ASP 87 A VAL 88 n 88 VAL 88 A GLU 89 n 89 GLU 89 A GLN 90 n 90 GLN 90 A PRO 91 n 91 PRO 91 A PHE 92 n 92 PHE 92 A SER 93 n 93 SER 93 A CYS 94 n 94 CYS 94 A THR 95 n 95 THR 95 A SER 96 n 96 SER 96 A LEU 97 n 97 LEU 97 A ASP 98 n 98 ASP 98 A ALA 99 n 99 ALA 99 A VAL 100 n 100 VAL 100 A VAL 101 n 101 VAL 101 A ASN 102 n 102 ASN 102 A TYR 103 n 103 TYR 103 A PHE 104 n 104 PHE 104 A VAL 105 n 105 VAL 105 A SER 106 n 106 SER 106 A HIS 107 n 107 HIS 107 A THR 108 n 108 THR 108 A LYS 109 n 109 LYS 109 A LYS 110 n 110 LYS 110 A ALA 111 n 111 ALA 111 A LEU 112 n 112 LEU 112 A VAL 113 n 113 VAL 113 A PRO 114 n 114 PRO 114 A PHE 115 n 115 PHE 115 A LEU 116 n 116 LEU 116 A LEU 117 n 117 LEU 117 A ASP 118 n 118 ASP 118 A author_defined_assembly 1 monomeric 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 x,y,z identity operation 0.0000000000 0.0000000000 0.0000000000 A N LEU 47 A N LEU 47 A O THR 61 A O THR 61 A N THR 62 A N THR 62 A O ARG 73 A O ARG 73 1 A GLU 8 -53.34 174.46 1 A VAL 9 -37.20 -30.05 1 A LEU 10 33.16 46.13 1 A ARG 17 34.85 45.56 1 A LEU 31 -37.22 -36.53 1 A ALA 33 -39.42 -27.01 1 A CYS 43 -86.10 38.25 1 A SER 51 -63.86 -179.61 1 A ASN 67 43.08 26.32 1 A PRO 82 -69.70 3.37 1 A PRO 91 -69.75 82.30 1 A ALA 111 -69.55 96.27 2 A LEU 10 -68.91 94.33 2 A LYS 12 34.15 33.70 2 A ALA 33 -37.54 -37.73 2 A TYR 40 -117.61 79.79 2 A ASN 67 41.79 29.92 2 A ASP 87 -90.16 41.29 2 A PRO 91 -69.76 85.05 2 A PHE 92 -60.64 98.55 2 A ALA 111 -51.33 100.64 3 A ARG 17 -102.51 50.09 3 A ASP 53 -102.54 -64.88 3 A ASP 56 -54.25 94.12 3 A PRO 82 -69.81 0.93 3 A ILE 86 -42.27 152.36 3 A PRO 91 -69.79 88.96 4 A ALA 18 -114.38 73.86 4 A SER 29 -68.47 -179.92 4 A MET 65 -41.98 100.32 4 A ASP 87 -87.34 42.91 4 A PRO 91 -69.67 88.33 4 A LYS 109 -49.95 -70.28 5 A LEU 10 -54.15 99.89 5 A LYS 12 -82.04 38.94 5 A ASN 45 -131.50 -40.68 5 A ASP 87 -91.14 45.60 5 A PRO 91 -69.74 93.02 5 A HIS 107 -41.59 -70.09 6 A LYS 12 32.04 36.53 6 A PHE 25 -44.50 156.12 6 A TYR 40 -119.62 78.98 6 A SER 51 -51.57 179.42 6 A PRO 82 -69.81 3.07 6 A ASP 87 -82.81 46.42 6 A PRO 91 -69.76 86.80 7 A LEU 10 -50.48 94.36 7 A ALA 11 -36.31 153.79 7 A LYS 12 -39.00 116.36 7 A ARG 17 -89.51 43.24 7 A SER 51 -95.91 38.45 7 A ASP 56 34.45 43.38 7 A ILE 86 -47.92 156.08 7 A ASP 87 -91.69 46.38 7 A PRO 91 -69.81 86.38 7 A ALA 111 -43.35 99.75 8 A ALA 11 -46.71 174.76 8 A LYS 12 -53.59 103.27 8 A ARG 17 34.24 39.63 8 A ASP 53 -124.80 -58.34 8 A ASN 67 71.30 36.71 8 A PRO 82 -69.84 2.96 8 A PRO 91 -69.81 90.41 8 A ALA 111 -59.83 109.00 9 A LYS 12 33.37 33.31 9 A ALA 18 70.05 36.61 9 A ASN 45 -130.88 -32.00 9 A PRO 82 -69.82 2.86 9 A PRO 91 -69.73 89.01 10 A LYS 12 37.33 41.47 10 A ALA 18 -108.69 65.52 10 A TYR 40 -108.71 78.77 10 A ASP 53 -96.80 42.23 10 A MET 65 -69.19 97.99 10 A PRO 82 -69.70 2.71 10 A ASP 87 -68.09 74.32 10 A PRO 91 -69.74 89.18 10 A THR 108 -58.66 -177.07 10 A LYS 109 -40.78 151.53 10 A LYS 110 -33.05 -34.91 11 A GLU 8 -49.96 -179.16 11 A VAL 9 -34.22 113.38 11 A ARG 17 -76.63 48.18 11 A ALA 18 -93.02 58.77 11 A PHE 25 -43.76 154.56 11 A ASP 56 -98.58 41.42 11 A PRO 91 -69.81 86.39 11 A LYS 110 -41.92 163.69 12 A VAL 9 -35.13 -34.17 12 A LEU 10 33.50 50.94 12 A ARG 17 -50.95 171.90 12 A ALA 33 -36.50 -35.69 12 A PRO 91 -69.74 88.19 13 A ALA 11 -55.14 -175.31 13 A ARG 17 -77.62 47.60 13 A LEU 19 -109.52 -63.18 13 A GLU 20 -38.72 -37.60 13 A GLU 32 -36.75 -39.77 13 A CYS 43 -85.59 37.93 13 A ASN 45 -132.92 -52.62 13 A LEU 46 -50.07 89.46 13 A PRO 91 -69.71 85.50 13 A THR 108 -54.54 -174.98 14 A ALA 15 38.30 26.31 14 A PHE 25 -49.38 152.10 14 A ALA 33 -34.06 -38.53 14 A TYR 40 -119.13 76.59 14 A ASN 67 39.30 41.28 14 A PRO 91 -69.67 85.01 15 A GLU 8 -48.31 -18.99 15 A VAL 9 -173.64 143.34 15 A ARG 17 -91.22 59.55 15 A PHE 25 -45.98 153.16 15 A TYR 40 -114.08 76.52 15 A HIS 66 -69.81 -178.88 15 A ASN 67 -33.66 -39.24 15 A PRO 82 -69.75 3.02 15 A PRO 91 -69.68 86.36 16 A LEU 10 -87.74 44.74 16 A ALA 33 -33.84 -38.21 16 A TYR 40 -116.30 78.14 16 A CYS 43 -84.34 35.69 16 A LEU 46 -64.19 98.36 16 A ASN 67 -33.32 93.00 16 A PRO 91 -69.78 86.57 16 A VAL 105 -35.86 -33.35 16 A THR 108 -34.27 131.20 16 A LEU 112 -162.35 110.17 17 A ARG 17 34.11 53.21 17 A ALA 33 -34.06 -33.26 17 A ASN 45 -132.32 -32.54 17 A PRO 82 -69.89 2.02 17 A PRO 91 -69.80 91.94 17 A THR 108 -36.84 155.82 17 A LYS 109 -33.29 -75.13 18 A SER 2 -170.59 136.13 18 A SER 5 -173.47 114.49 18 A ALA 11 -37.06 -72.75 18 A LYS 12 -163.49 105.04 18 A ARG 17 -55.57 96.50 18 A TYR 40 -119.54 71.45 18 A ASP 53 -125.16 -54.11 18 A ASN 67 45.34 28.89 18 A PRO 82 -69.81 2.50 18 A ASP 87 -89.52 43.87 18 A PRO 91 -69.69 81.02 18 A ALA 111 -34.59 113.19 19 A PHE 25 -45.48 152.50 19 A ALA 33 -34.59 -37.49 19 A ASP 87 -93.29 52.53 19 A PRO 91 -69.69 85.96 20 A SER 6 -101.01 40.36 20 A ALA 15 -170.95 141.10 20 A ARG 17 -86.52 41.73 20 A PHE 25 -46.96 150.07 20 A GLN 34 -59.51 -70.26 20 A CYS 43 -87.30 35.53 20 A ASN 45 -130.04 -44.06 20 A LEU 46 -58.04 89.60 20 A ASP 53 -90.07 48.40 20 A ASP 87 -94.79 45.85 20 A PRO 91 -69.68 87.05 20 A ALA 111 -54.55 104.07 Solution structure of the human STAP2 SH2 domain 1 N N A SER 29 A SER 29 HELX_P A TYR 40 A TYR 40 1 1 12 A SER 96 A SER 96 HELX_P A THR 108 A THR 108 1 2 13 SIGNALING PROTEIN SH2 domain, Phosphotyrosine binding domain, Protein Tyrosine Kinase, Signal Transduction, Structural Genomics, NPPSFA, National Project on Protein Structural and Functional Analyses, RIKEN Structural Genomics/Proteomics Initiative, RSGI, SIGNALING PROTEIN STAP2_HUMAN UNP 1 137 Q9UGK3 EVLAKEEARRALETPSCFLKVSRLEAQLLLERYPECGNLLLRPSGDGADGVSVTTRQMHNGTHVVRHYKVKREGPKYVID VEQPFSCTSLDAVVNYFVSHTKKALVPFLLD 137 247 2EL8 8 118 Q9UGK3 A 1 8 118 1 expression tag GLY 1 2EL8 A Q9UGK3 UNP 1 1 expression tag SER 2 2EL8 A Q9UGK3 UNP 2 1 expression tag SER 3 2EL8 A Q9UGK3 UNP 3 1 expression tag GLY 4 2EL8 A Q9UGK3 UNP 4 1 expression tag SER 5 2EL8 A Q9UGK3 UNP 5 1 expression tag SER 6 2EL8 A Q9UGK3 UNP 6 1 expression tag GLY 7 2EL8 A Q9UGK3 UNP 7 3 anti-parallel anti-parallel A LEU 47 A LEU 47 A PRO 50 A PRO 50 A VAL 58 A VAL 58 A THR 62 A THR 62 A ARG 73 A ARG 73 A TYR 75 A TYR 75